Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03663712
Title Talimogene Laherparepvec for the Treatment of Peritoneal Surface Malignancies (TEMPO)
Acronym TEMPO
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dan Blazer III, M.D.
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Illinois College of Medicine at Chicago Chicago Illinois 60612 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Wake Forest University School of Medicine Winston-Salem North Carolina 27013 United States Details
*Shaded cells indicate that there was no data available from for the field